Manulife (Manufacturers Life Insurance)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-600	Closed	-$33K	–	3595
2018 Q2	$33K	Hold	600	–	–	﹤0.01%	3643
2018 Q1	$30K	Hold	600	–	–	﹤0.01%	3665
2017 Q4	$28K	Hold	600	–	–	﹤0.01%	3704
2017 Q3	$30K	Hold	600	–	–	﹤0.01%	3593
2017 Q2	$27K	Buy	600 +300	+100%	+$12.9K	﹤0.01%	3613
2017 Q1	$13K	Sell	300 -200	-40%	-$8.38K	﹤0.01%	3606
2016 Q4	$19K	Sell	500 -200	-29%	-$8.07K	﹤0.01%	3644
2016 Q3	$29K	Buy	700 +200	+40%	+$8.21K	﹤0.01%	3504
2016 Q2	$19K	Buy	+500	New	+$19.6K	﹤0.01%	3522

Other funds holding PBE

ACM

Arlington Capital Management Arlington Heights, Illinois $161M AUM 38.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

AFM

Abbot Financial Management Andover, Massachusetts $293M AUM 36.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PBE Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2018, closing a stake of 600 shares — an estimated $33K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PBE in Q2 2016 and held it in 9 quarters. The position peaked at $33K in Q2 2018. 74 funds tracked by Wall St. Rank hold PBE as of Q3 2018.

Manulife (Manufacturers Life Insurance) reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2018 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 600 Invesco Biotechnology & Genome ETF shares in Q3 2018, an estimated $33K.
Manulife (Manufacturers Life Insurance) first reported a position in Invesco Biotechnology & Genome ETF in Q2 2016 and held it in 9 quarters.
Manulife (Manufacturers Life Insurance)'s Invesco Biotechnology & Genome ETF position peaked at $33K in Q2 2018.
74 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.